One-year trial of pergolide as an adjunct to Sinemet in treatment of Parkinson's disease.
D001264:Athetosis / Q000188:drug therapy; D002230:Carbidopa / Q000008:administration & dosage*; D002819:Chorea / Q000188:drug therapy; D004338:Drug Combinations / Q000008:administration & dosage; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D004873:Ergolines / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D007022:Hypotension / Q000139:chemically induced; D007980:Levodopa / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy*; D010479:Pergolide
D004338:Drug Combinations; D004873:Ergolines; C009265:carbidopa, levodopa drug combination; D010479:Pergolide; D007980:Levodopa; D002230:Carbidopa